Clinical Trial Update: Relovair PD PK in Chinese Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study of Relovair in Chinese healthy subjects has been completed. The trial evaluated the PK/PD profile of Relovair …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RELOVAIR

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED